mg Tablets,
Sponsors
Novartis (Thailand) Ltd., T.O. Chemicals (1979) Ltd.
Conditions
Healthy volunteers
Healthy volunteers
Bioequivalence
Febuxostat
Pharmacokinetic studyHealthy volunteers
Healthy volunteers
Bioequivalence
Rivaroxaban
Pharmacokinetic studyHealthy volunteers
Healthy volunteers
Bioequivalence
Sitagliptin
Metiformin
Fixed dose combunation tablets
Pharmacokinetic studyHealthy volunteers
Pantoprazole
Bioequivalence
PharmacokineticsHealthy volunteers
Sitagliptin
Bioequivalence
Pharmacokinetics
Phase 1
A Bioequivalence Study of Two Formulations of 10-mg Rivaroxaban Tablets in Healthy Thai Volunteers under Fasted Condition
Active, not recruitingTCTR20190430003
Start: 2019-09-17Target: 56Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of 20-mg Rivaroxaban Tablets in Healthy Thai Volunteers under Fed Condition
Active, not recruitingTCTR20190503001
Start: 2019-08-06Target: 24Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of Sitagliptin Phosphate Film-coated Tablet Equivalent to 100 mg Sitagliptin in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20200108002
Start: 2020-05-18Target: 32Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of Sitagliptin Phosphate Film-coated Tablet Equivalent to 100 mg Sitagliptin in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20200108002
Start: 2020-05-18Target: 32Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of 40-mg Pantoprazole (as Pantoprazole Sodium Sesquihydrate) Gastro-resistant Tablets in Healthy Thai Volunteers under Fed Conditions
Active, not recruitingTCTR20200116005
Start: 2020-03-02Target: 32Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of 20-mg Rivaroxaban Tablets in Healthy Thai Volunteers under Fed Condition
Active, not recruitingTCTR20200513006
Start: 2020-08-25Target: 40Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of Sitagliptin Phosphate Equivalent to Sitagliptin 50 mg and Metformin Hydrochloride 500 mg in Healthy Thai Volunteers under Fed Conditions
Active, not recruitingTCTR20200604004
Start: 2020-10-12Target: 32Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of Sitagliptin Phosphate Equivalent to Sitagliptin 50 mg and Metformin Hydrochloride 1000 mg in Healthy Thai Volunteers under Fed Conditions
Active, not recruitingTCTR20200605001
Start: 2020-09-01Target: 32Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of 80-mg Febuxostat Tablets in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20201221003
Start: 2021-10-04Target: 64Updated: 2026-08-03